… be immunohistochemically detected with an antibody to the carboxy terminus of ret (16,
17). We applied this triad of immunohistochemical stains to a spectrum of thyroid lesions to …

… immunohistochemical detection of the mutated BRAF V600E protein is a reliable, highly
specific method for detection … of mutated BRAF in papillary microcarcinomas. Expression of …

… , α-catenin and βcatenin expressions in papillary thyroid carcinoma (PTC) and to correlate the
… A retrospective immunohistochemical analysis of E-cadherin, α-catenin and β-catenin was …

… PTCs from benign thyroid lesions. Studies have shown that immunohistochemical staining for
… reported that the combined detection of two or more immunohistochemical markers did not …

… In a recent study, p63 was detected in papillary carcinoma, Hashimoto’s thyroiditis, and in …
thyroid. In the present study, the relationship between solid cell nests and papillary carcinoma …

… rate in benign thyroid lesions was low (2%, 1/50). Therefore, our results showed that BRAF
V600E IHC detection was specific for PTC diagnosis, as well as gene mutation detection, …

… be expressed by the clinically high-rsk group of patients with papillary thyroid carcinoma. …
We used human papillary thyroid carcinomas (n = 21), follicular thyroid carcinomas (n = 2), …

… was different from the section used for IHC, care was taken to use … immunohistochemical
detection of the mutated BRAF V600E protein is a reliable, highly specific method for detection …

… To compare the results of IHC and real time PCR (RT-PCR) in the detection of BRAF V600E
mutation in papillary thyroid carcinoma. Analysis of clinical and pathological differences …

… The objective of this study was to verify the usefulness of IHC detection of the BRAF V600E
mutation in thyroid carcinoma using the VE1 antibody. IHC detection of BRAF V600E was …